qPCR Instruments Industry Overview
The global qPCR instruments market size to be valued at USD 1.39 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of 3.4% during the forecast period.
The growing prevalence of diseases, technological advancements, and increasing demand for qPCR instruments are anticipated to drive the market over the forecast period. Increased focus on diagnostics attributed to the spread of COVID-19 is projected to propel the demand for qPCR instruments in the upcoming years. The demand for qPCR equipment and consumables is being driven by the SARS-CoV-2 pandemic. The spike in the incidence of COVID-19 is expected to add significantly to the number of preventive screenings. This can be attributed to the fact that the number of COVID-19 patients cannot be ascertained without proper screening owing to a large number of asymptomatic cases.
Gather more insights about the market drivers, restrains and growth of the Global qPCR Instruments Market
The launch of new products is expected to change certain market dynamics as it can increase the threat of internal substitution. Furthermore, increasing consumers’ preference for updated and advanced products is creating a demand for technologically advanced products, such as the Mic qPCR system with Bluetooth connectivity and multiple devices that can be connected to the computer simultaneously to run multiple sample sets.
The prevalence of chronic diseases, infectious diseases, and genetic disorders, such as Alzheimer’s, Turner syndrome, and Parkinson’s, has increased rapidly, which is expected to fuel the market growth. According to the CDC, chronic diseases such as cancer, diabetes, kidney diseases, and respiratory diseases, including asthma, are accountable for 7 in 10 deaths in the U.S. each year. Faster detection of diseases with PCR can allow for timely and appropriate treatment.
Increasing adoption of qPCR technologies is expected to propel this market growth. The adoption of qPCR techniques is increasing owing to their accuracy, automation, precise results, real-time quantification, and sensitivity. qPCR offers a wide range of input nucleic acids, making it an effective and useful technology in research applications.
Browse through Grand View Research's Clinical Diagnostics Industry Research Reports
- Central Lab Market: The global central lab market size was valued at USD 2.84 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030.
- Polymerase Chain Reaction Market: The global polymerase chain reaction market size was valued at USD 37.36 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030.
qPCR Instruments Market Segmentation
Grand View Research has segmented the global qPCR instruments market based on instrument and region:
qPCR Instruments Outlook (Revenue, USD Million, 2017 - 2028)
- 7500
- QuantStudioDx Real-Time PCR System
- QuantStudio 5 Real-Time PCR System
- ViiA 7 Dx
- StepOne/ StepOne Plus
- LightCycler 2.0/ 96/ 480/ 1536
- Cobas 4800
- CFX96
- SmartCycler
- GeneXpert
- Rotor-Gene Q 5Plex HRM System
- Rotor-Gene Q
- BioFire FilmArray Systems
- BMS Mic System
qPCR Instruments Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Market Share Insights
- June 2022: Bio-Rad Laboratories, Inc., an American developer, and manufacturer of specialized technology products launched the CFX Duet Real-Time PCR System. The CFX Duet Technology combines Bio-CFX Rad's Opus System's robust thermal performance and patented, precise optical shuttle system with thermal grading functionality to allow optimization in fewer runs
- May 2022: Thermo Fisher Scientific, Inc., an American supplier of scientific instrumentation, reagents, and consumables announced the launch of the QualTrak Biopharma qPCR instrument. The new QualTrak qPCR Solutions will aid in the rapid creation of new biologics to fulfill the growing demand.
Key Companies profiled:
Some prominent players in the global qPCR instruments market include:
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Qiagen
- Agilent Technologies, Inc.
- Abbott
- bioMérieux SA
- Quantabio
- Azure Biosystems, Inc.
- Bio Molecular Systems
Order a free sample PDF of the qPCR Instruments Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
